Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transition Metal Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Mo/Cu co-catalyzed method offers mild conditions and high yields for critical heterocyclic scaffolds used in drug discovery.
Patent CN113307778A reveals a mild Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering reliable pharmaceutical intermediate supply and cost efficiency.
Novel Rh-catalyzed method for benzimidazo[1,2-a]quinolines using ionic liquids. High yield, additive-free process for pharma intermediates.
Patent CN113307778A reveals a mild Mo/Cu-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Discover a novel one-step C-H activation method for 3-acylated indoles. This patent-pending route offers mild conditions and high yields for pharmaceutical intermediates.
Patent CN107459533B discloses stable phosphine ligands enabling low-loading palladium catalysis. Discover cost-effective solutions for pharmaceutical intermediate manufacturing.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Novel Rh-catalyzed aminocarbonylation using dimethyl carbonate offers a green, high-yield route for acetamide production, ensuring cost-effective supply chain solutions.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for API manufacturing.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of key heterocyclic building blocks.
Patent CN106946875A details green synthesis for high-purity imidazole intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN111423381B reveals a mild palladium-catalyzed route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN111978194B details a novel Pd-catalyzed carbonylation using benzyl formate. Offers cost-effective, scalable routes for pharmaceutical intermediates.
Patent CN112961086A introduces a novel rhodium-catalyzed one-step synthesis method for high-purity pharmaceutical intermediates with significant cost reduction potential through streamlined manufacturing processes.
Discover scalable ruthenium-catalyzed N-acylpyrrole synthesis with 80% yield. Reduce costs and supply chain risks for pharma R&D and procurement with simplified industrial processes.
Discover a novel one-pot synthesis method for pyrazolo[5,1-a]isoindole-3-carboxamide with 82% yield, eliminating intermediate purification. Reduce costs and environmental impact in your pharmaceutical production.
Solve multi-step synthesis challenges with high-yield, one-pot 2-methylene-1-indanone production. Reduce costs and supply risks for API development.
Struggling with low yields in dihydrophenanthrene synthesis? Discover the latest rhodium-catalyzed method for trifluoromethyl derivatives with high purity and air stability. Find reliable suppliers for API intermediates.
Struggling with low-yield tetrahydro-β-carbolinone synthesis? Discover emerging cobalt-catalyzed C-H carbonylation methods for high-purity API intermediates. Find reliable suppliers now.